Moleculin Biotech, Inc. (MBRX) › Shareholders' EquityMoleculin Biotech, Inc. (MBRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$745.0K2016: $14.96M2017: $17.12M2018: $14.27M2019: $15.57M2020: $17.76M2021: $78.99M2022: $52.19M2023: $30.93M2024: $11.21M2025: $15.01M$15.01M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$15.01M+33.9%2024$11.21M-63.8%2023$30.93M-40.7%2022$52.19M-33.9%2021$78.99M+344.8%2020$17.76M+14.1%2019$15.57M+9.1%2018$14.27M-16.6%2017$17.12M+14.4%2016$14.96M+2108.1%2015-$745.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share